Study of OsrhAAT or Placebo in Healthy Volunteers

Clinical trial NCT05315921 · UNKNOWN

Trial details

NCT number: NCT05315921
Sponsor: Healthgen Biotechnology Corp.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Emphysema Secondary to Congenital AATD

Start date: 2022-03-22
Primary completion: 2023-03-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.